Detalhe da pesquisa
1.
Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
Blood
; 2024 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657242
2.
Rate and characteristics of inflammatory neuropathies associated with brentuximab vedotin therapy.
Eur J Neurol
; : e16285, 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38511878
3.
Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series.
Blood
; 143(8): 734-737, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38096365
4.
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.
Br J Haematol
; 193(3): 674-677, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33713427
5.
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study.
ESC Heart Fail
; 11(3): 1707-1719, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444090
6.
Amylo-AFFECT-QOL, a self-reported questionnaire to assess health-related quality of life and to determine the prognosis in cardiac amyloidosis.
Front Cardiovasc Med
; 10: 1124660, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36998975
7.
Changes in amyloidosis phenotype over 11 years in a cardiac amyloidosis referral centre cohort in France.
Arch Cardiovasc Dis
; 116(10): 433-446, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37640624
8.
Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies.
Clin Microbiol Infect
; 28(6): 885.e7-885.e11, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35259530
9.
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment.
Leuk Lymphoma
; 62(4): 979-983, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33251891